Quantcast

Axis-Shield Diagnostics Limited Signs a Licensing and Development Deal with Siemens Healthcare for Its Proprietary Active-B12 Test

December 19, 2013

Axis-Shield Diagnostics Limited Signs a Licensing and Development Deal with Siemens Healthcare for Its Proprietary Active-B12 Test

Dundee, Scotland (PRWEB) December 19, 2013

Axis-Shield Diagnostic Limited an international provider of in vitro diagnostic reagents, announces that it has concluded a licensing, development and supply arrangement with Siemens Healthcare Diagnostics, a global leader in clinical diagnostics headquartered in Tarrytown, New York, to incorporate its proprietary ActiveB12 (HoloTranscobalamin) test for the diagnosis of Vitamin B12 deficiency on the Siemens ADVIA Centaur Immunoassay System.

Vitamin B12 deficiency poses a significant public health problem; for example, in the USA, 3-6% of adults are estimated to have vitamin B12 deficiency, and globally incidence will increase as the population ages. Although the deficiency can be treated with Vitamin B12 supplements, it has been associated with the development of neurodegenerative conditions, some of which may be irreversible, and early detection can play a critical role in preventing permanent neurological damage.

For further enquiries, please contact:

Axis-Shield Diagnostic Limited    

Dr Anil Vasishta, Commercial Director             Tel: +44 1382422000

About Alere    

By developing new capabilities in near-patient diagnosis, monitoring and health information technology, Alere enables individuals to take charge of improving their health and quality of life at home. Alere's global leading products and services, as well as its new product development efforts, focus on infectious disease, cardiology, toxicology and diabetes. Alere is headquartered in Waltham, Massachusetts. For more information regarding Alere, please visit http://www.alere.com.

About Axis-Shield Diagnostics Limited

Headquartered in Dundee with R&D and manufacturing facilities Axis-Shield is a leading international and innovative company operating in faster growing segments of the in vitro diagnostics (IVD) market. Axis-Shield serves the clinical laboratory through the development of novel tests, particularly for the high throughput analysers of blue-chip original equipment manufacturers (OEMs). For more information on Axis-Shield, please refer to http://www.axis-shield.com.

For the original version on PRWeb visit: http://www.prweb.com/releases/2013/12/prweb11429996.htm


Source: prweb



comments powered by Disqus